
BKV Major capsid protein VP1 108-116, LLMWEAVTV
Description
About BKV Major capsid protein VP1 108-116, LLMWEAVTV
The BK Polyomavirus (BKV) (strain AS) Capsid protein (Major VP1) Peptide (IEDB: 37590) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Capsid protein Peptide, H-LLMWEAVTV-OH (Uniprot: P14996 aa: 108-116) from JPT is produced under strict quality control and quality management.
BKV Major capsid protein VP1 108-116, LLMWEAVTV - Specifications
- Peptide sequence: H-LLMWEAVTV-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Infection
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for BKV Major capsid protein VP1 108-116, LLMWEAVTV
References:
Read References with JPT’s Antigen Peptides
BKV (strain AS) Major capsid protein VP1 108-116, LLMWEAVTV has been described in:
An SV40 VP1-derived epitope recognized by CD8+ T cells is naturally processed and presented by HLA-A*0201 and cross-reactive with human polyomavirus determinants., Virology, 2008 (PMID: 18402997)
Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides., J Virol, 2005 (PMID: 16103168)
Large scale analysis of peptide - HLA-I stability, nan, 2014 (PMID: Submission)
Documentation
Documentation for BKV Major capsid protein VP1 108-116, LLMWEAVTV
Properties
Properties of BKV Major capsid protein VP1 108-116, LLMWEAVTV
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Infection |
Layout: | Freeze-dried in glass vial |
Organism: | BK Polyomavirus (BKV) |
Protein Name: | Capsid protein |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to BKV Major capsid protein VP1 108-116, LLMWEAVTV
Information | Values |
---|---|
Sequence: | H-LLMWEAVTV-OH |
Specifications: | 9mer peptide as TFA salt |